News

Nitec Pharma (Nitec) has reported positive results from the second pivotal phase III trial for its lead product, Lodotra for the treatment of rheumatoid arthritis (RA). The CAPRA-2

MethylGene has initiated its phase II program (Trial 103) evaluating MGCD265, the company’s multi-targeted (c-Met) kinase inhibitor, in combination with approved anticancer agents Tarceva and docetaxel. The trial

Ranbaxy Pharmaceuticals (RPI), a wholly owned subsidiary of Ranbaxy has entered into an agreement with Validus Pharmaceuticals (Validus) to market and distribute an authorized generic version of Rocaltrol

BioTech Medics has received preliminary independent clinical testing of its patented shban hand sanitizer solution to demonstrate that it kills the H1N1 (Swine) Influenza A virus. Preliminary lab

Sinovac Biotech has signed an agreement with Boryung Pharmaceutical to collaborate on marketing efforts and possible vaccine supply efforts to the government of South Korea for Sinovac’s H1N1

Madrona Ventures has acquired the Obesity treatment’s European patent and the pending American patent application. Reportedly, the company will be starting the phase II double-blind placebo-controlled clinical trial

Meda has received FDA approval for Astepro (azelastine) nasal spray 0.15%, for the treatment of the symptoms of seasonal and perennial allergic rhinitis. The new Astepro nasal spray

Unilife Australia has entered into a Merger Implementation Agreement with Unilife Corporation (Unilife US), a wholly owned subsidiary of Unilife Australia. The purpose of the Merger Implementation Agreement

Bayer CropScience has successfully ended a patent infringement dispute in China with the two Chinese companies Jiangsu Tian Rong Group (Tian Rong) and Yixing Hua Dong Agrochemical (Hua